- Home
- PRME vs EB Comparison
PRME vs EB Comparison
Compare PRME & EB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- EB
- Stock Information
- Founded
- PRME 2019
- EB 2008
- Country
- PRME United States
- EB United States
- Employees
- PRME N/A
- EB N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- EB EDP Services
- Sector
- PRME Health Care
- EB Technology
- Exchange
- PRME Nasdaq
- EB Nasdaq
- Market Cap
- PRME 379.1M
- EB 324.6M
- IPO Year
- PRME 2022
- EB 2018
- Fundamental
- Price
- PRME $2.97
- EB $3.26
- Analyst Decision
- PRME Strong Buy
- EB Buy
- Analyst Count
- PRME 9
- EB 6
- Target Price
- PRME $13.13
- EB $6.70
- AVG Volume (30 Days)
- PRME 1.0M
- EB 653.3K
- Earning Date
- PRME 03-04-2025
- EB 02-27-2025
- Dividend Yield
- PRME N/A
- EB N/A
- EPS Growth
- PRME N/A
- EB N/A
- EPS
- PRME N/A
- EB N/A
- Revenue
- PRME $800,000.00
- EB $336,368,000.00
- Revenue This Year
- PRME N/A
- EB $2.57
- Revenue Next Year
- PRME $477.62
- EB $4.11
- P/E Ratio
- PRME N/A
- EB N/A
- Revenue Growth
- PRME N/A
- EB 8.54
- 52 Week Low
- PRME $2.25
- EB $2.51
- 52 Week High
- PRME $9.77
- EB $8.46
- Technical
- Relative Strength Index (RSI)
- PRME 53.25
- EB 43.47
- Support Level
- PRME $2.25
- EB $3.32
- Resistance Level
- PRME $3.36
- EB $3.41
- Average True Range (ATR)
- PRME 0.23
- EB 0.15
- MACD
- PRME 0.07
- EB -0.00
- Stochastic Oscillator
- PRME 64.41
- EB 43.40
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About EB Eventbrite Inc.
Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. It is engaged in creating a platform to enable creators to solve many challenges associated with creating live experiences. The Company's platform integrates components needed to seamlessly plan, promote and produce live events. Its platform helps to plan, promote and produce live events, thereby allowing creators to reduce friction and costs, increase reach and drive ticket sales. Geographically, it generates maximum revenue from the United States.